KCNQ1 — Drug Target

All drugs that target KCNQ1 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

KCNQ1 potassium channel activator · Potassium channel opener

Phase 3 pipeline (1)

• Etavopivat Tablets Low dose · Forma Therapeutics, Inc. · KCNQ1 potassium channel activator · Hematology/Oncology
  Etavopivat activates the KCNQ1 potassium channel to increase fetal hemoglobin (HbF) production in red blood cells.

Phase 2 pipeline (1)

• IMR-687 · Cardurion Pharmaceuticals, Inc. · Potassium channel opener · Cardiovascular
  Potassium channel opener